Financial reports
N-CEN
Annual report (registered investment company)
12 Mar 24
N-CSR
Certified annual shareholder report (management investment company)
15 Feb 24
N-CSR
Certified annual shareholder report (management investment company)
15 Feb 24
N-CSR
Certified annual shareholder report (management investment company)
15 Feb 24
N-CSR
Certified annual shareholder report (management investment company)
15 Feb 24
N-CSR
Certified annual shareholder report (management investment company)
15 Feb 24
N-CSR
Certified annual shareholder report (management investment company)
15 Feb 24
N-CSR
Certified annual shareholder report (management investment company)
15 Feb 24
N-CSRS
Certified semi-annual shareholder report (management investment company)
22 Aug 23
N-CSRS
Certified semi-annual shareholder report (management investment company)
22 Aug 23
Current reports
No filings
Registration and prospectus
Proxies
N-PX
Annual report of proxy voting record
31 Aug 23
DEF 14A
Definitive proxy
16 Jun 23
DEF 14A
Definitive proxy
16 May 23
DEF 14A
Definitive proxy
28 Apr 23
N-PX
Annual report of proxy voting record
31 Aug 22
N-PX
Annual report of proxy voting record
31 Aug 21
DEF 14A
Definitive proxy
17 May 21
DEF 14A
Definitive proxy
5 May 21
DEF 14A
Definitive proxy
27 Apr 21
DEF 14A
Definitive proxy
22 Apr 21
Ownership
NPORT-P
Monthly portfolio investment report
26 Feb 24
NPORT-P
T. Rowe Price Blue Chip Growth Portfolio (Dec 2023 report)
26 Feb 24
NPORT-P
Monthly portfolio investment report
26 Feb 24
NPORT-P
T. Rowe Price Mid-Cap Growth Portfolio (Dec 2023 report)
26 Feb 24
NPORT-P
T. Rowe Price Moderate Allocation Portfolio (Dec 2023 report)
26 Feb 24
NPORT-P
T. Rowe Price All-Cap Opportunities Portfolio (Dec 2023 report)
26 Feb 24
NPORT-P
T. Rowe Price Equity Income Portfolio (Dec 2023 report)
26 Feb 24
NPORT-P
T. Rowe Price Equity Index 500 Portfolio (Sep 2023 report)
28 Nov 23
NPORT-P
T. Rowe Price Blue Chip Growth Portfolio (Sep 2023 report)
28 Nov 23
NPORT-P
T. Rowe Price Health Sciences Portfolio (Sep 2023 report)
28 Nov 23